SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-048746
Filing Date
2023-06-14
Accepted
2023-06-14 08:37:31
Documents
3
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea180350-6k_nlspharma.htm 6-K 11050
2 PRESS RELEASE TITLED: "NLS PHARMACEUTICS ANNOUNCES POSITIVE SAFETY DATA FROM IN ea180350ex99-1_nlspharma.htm EX-99.1 23110
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5536
  Complete submission text file 0001213900-23-048746.txt   42922
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 231013072
SIC: 2834 Pharmaceutical Preparations